FiercePharma19h
US' top IV fluid maker Baxter voices uncertainty about recovery timeline at North Carolina facility hit by Helene
After announcing the closure of its biggest manufacturing site Sunday due to flooding caused by Hurricane Helene, Baxter ...
FiercePharma18h
GSK, Sanofi, CSL nab $72M in BARDA funding to boost bird flu vaccine supply
CSL Seqirus, Sanofi and GSK have collectively secured $72 million in funding from the U.S. health department to boost the ...
FiercePharma21h
American Society for Meningitis Prevention paints the town purple and blue for World Meningitis Day
A nonprofit dedicated to improving vaccination rates to eradicate meningococcal meningitis is brightening things up this ...
FiercePharma21h
BeiGene launches PD-1 drug Tevimbra at 10% discount to Merck's Keytruda
BeiGene has officially launched its PD-1 cancer drug Tevimbra in the U.S. more than six months after receiving a much-delayed ...
FiercePharma22h
In sustained rare disease push, Recordati lays out $825M upfront to acquire Sanofi's CAD drug Enjaymo
As Sanofi continues to clean out its medicine chest, Italy’s Recordati is getting in on the action. | Recordati is floating ...
FiercePharma23h
Breaking down BIOSECURE—Industry implications and what comes next
Since the introduction of the BIOSECURE Act in January, named companies and U.S.-based biopharmas alike have speculate | This ...